Business

Asahi Kasei Expands Healthcare Materials Portfolio with Sonanos™ Next-Generation Excipients

TOKYO, October 09, 2025--Asahi Kasei announced the launch of two new specialty grades in its Sonanos portfolio.

articleAsahi Kasei CorporationOctober 9, 20253/company/asahi-kasei-corporation/news/asahi-kasei-expands-healthcare-materials-portfolio-with-sonanostm-next-generation-excipients
Asahi Kasei Expands Healthcare Materials Portfolio with Sonanos™ Next-Generation Excipients

About this update from Asahi Kasei Corporation

[{"type":"image","alt":"Sonanos™ nanogel structure and active pharmaceutical ingredient (API) encapsulation mechanism via hydrophobic interactions","displaySize":"","headline":null,"caption":"Sonanos™ nanogel structure and active pharmaceutical ingredient (API) encapsulation mechanism via hydrophobic interactions","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":215,"url":"https://media.zenfs.com/en/business-wire.com/dc455c6a9090d67de692d0e23d1d6fb9"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/GbSnVboimsnCVCvjLO4CVw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQzMDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/dc455c6a9090d67de692d0e23d1d6fb9","width":480,"height":215}},"lazy":false},{"type":"image","alt":"Sonanos™ supports injectable drug formulations","displaySize":"","headline":null,"caption":"Sonanos™ supports injectable drug formulations","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":270,"url":"https://media.zenfs.com/en/business-wire.com/644d2c6ae86a5daed06fbfe9b5394dd5"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/xD434kBKHHoEU6.yViX.PA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTU0MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/644d2c6ae86a5daed06fbfe9b5394dd5","width":480,"height":270}}},{"type":"image","alt":"Sonanos™ supply framework and development stages","displaySize":"","headline":null,"caption":"Sonanos™ supply framework and development stages","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":295,"url":"https://media.zenfs.com/en/business-wire.com/98101edab0496e5ca9ffa59b9f797e45"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/qKm5Qj8SdymPfEb2V7HQXw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTU5MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/98101edab0496e5ca9ffa59b9f797e45","width":480,"height":295}}},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":4999,"height":683,"url":"https://media.zenfs.com/en/business-wire.com/a577e3511e0c30622e5c0a440137bd8c"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/tM_s.BmycHN93eGpYDtw2g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTEzMTtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/a577e3511e0c3...

More updates from Asahi Kasei Corporation

Asahi Kaseiactive pharmaceutical ingredientactive pharmaceutical ingredientspharmaceutical companiespharmaceutical materialsGMPsustained releaseinjectable drug